On November 7, 2023 Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of T cell engagers to selectively modulate tumor-specific T cells, reported that it will participate in three investor conferences this November, the Stifel Healthcare Conference, to be held in New York from November 14-15, the Jefferies London Healthcare Conference, to be held in London from November 14-16, and the Piper Sandler Annual Healthcare Conference, to be held in New York from November 28-30 (Press release, Cue Biopharma, NOV 7, 2023, View Source [SID1234637185]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
During the presentations and fireside discussions, Cue Biopharma will provide a corporate overview including recent data highlights from its lead clinical programs, CUE-101 and CUE-102, representative of the IL-2-based CUE-100 series of selective T cell engagers.
Presentation Details
Stifel Healthcare Conference
Date and Time: Tuesday, November 14 from 1:50 p.m. EST–2:20 p.m. EST
Webcast Link: View Source
Presenter: Daniel Passeri, M.Sc., J.D., chief executive officer, Cue Biopharma
Jefferies London Healthcare Conference
Date and Time: Thursday, November 16 from 11:00 a.m. GMT–11:25 a.m. GMT
Webcast Link: View Source
Presenter: Daniel Passeri, M.Sc., J.D., chief executive officer, Cue Biopharma
Piper Sandler 35th Annual Healthcare Conference
Date and Time: Wednesday, November 29 at 4:00 p.m. EST–4:25 p.m. EST
Webcast Link: View Source;tp_key=a3f15c0417
Presenter: Daniel Passeri, M.Sc., J.D., chief executive officer, Cue Biopharma
Live and archived webcasts of the presentations and fireside chats will be available on the Events page in the Investors and Media section of the Company’s website at www.cuebiopharma.com. The webcasts will be archived for 30 days.